Read how Orion™ was used to identify improved prognostic signatures for colorectal cancer patients in this publication from Harvard Medical School. "High-plex immunofluorescence imaging and traditional histology of the same tissue section...

Researchers at Harvard Medical School and National Cheng Kung University in Taiwan have developed a new artificial intelligence (AI) tool that examines tumor sample images to provide doctors with prognoses and guidance on the most appropriate...

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and PathAI, a company that develops artificial intelligence technology for pathology, are collaborating with the aim to develop solutions that improve the precision...